Published in Telemedicine Week, July 4th, 2006
The biomaterial has been shown to be effectively visualized on four key imaging modalities; x-ray, ultrasound, CT and MRI. This discovery could eventually lead to Aion Diagnostics being competitively positioned in the multi-billion dollar imaging agent market.
"The discovery of BioSilicon's unique property in imaging has identified a key competitive advantage since previously only combinations of materials could achieve these properties,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week